Strategic Partnerships Splash Beverage Group recently entered into an exclusive global licensing agreement with Argent BioPharma Limited for CannEpil, indicating a strategic path into cannabinoid-based therapeutics across multiple European markets that can inspire cross-sell opportunities with pharma distributors and wellness channels.

Leadership Transitions There have been recent leadership changes with an interim CEO appointed, a CEO transition timeline, and board additions. This suggests a window for engaging senior decision-makers and aligning proposals with evolving strategic priorities during the transition period.

Product Diversification The company has launched Chispo Tequila and maintains a portfolio spanning hemp-based, alcoholic, and non-alcoholic brands, signaling opportunities to propose distribution, co-manufacturing, or private-label partnerships across multiple beverage categories and retail channels.

Compliance and Growth Readiness NYSE compliance challenges and ongoing plans to restore compliance imply heightened corporate governance activity and potential readiness for scaled distribution partnerships, capital-friendly financing discussions, and vendor diligence alignment.

Financial Scale With estimated revenue in the 10 to 25 million range and total funding around 12 million, there is a tangible growth trajectory that can be supported with strategic channel expansion, regional partnerships, and performance-based marketing collaborations to accelerate market penetration.